BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,937,000 | +909.8% | 45,892 | +872.9% | 0.95% | +914.9% |
| Q2 2022 | $687,000 | -98.7% | 4,717 | -98.9% | 0.09% | -98.1% |
| Q1 2022 | $51,356,000 | -19.6% | 433,124 | -6.5% | 4.95% | -15.6% |
| Q4 2021 | $63,860,000 | -1.5% | 463,392 | -0.7% | 5.86% | -9.6% |
| Q3 2021 | $64,825,000 | +19.6% | 466,668 | -16.4% | 6.49% | +17.4% |
| Q2 2021 | $54,198,000 | +41.2% | 558,286 | -0.6% | 5.52% | +23.9% |
| Q1 2021 | $38,375,000 | -20.0% | 561,442 | +0.4% | 4.46% | -24.5% |
| Q4 2020 | $47,949,000 | +31.8% | 559,437 | -0.0% | 5.90% | +3.2% |
| Q3 2020 | $36,378,000 | -17.8% | 559,574 | -7.5% | 5.72% | -31.3% |
| Q2 2020 | $44,249,000 | +115.6% | 605,242 | +0.4% | 8.33% | +68.1% |
| Q1 2020 | $20,521,000 | -35.6% | 603,036 | +3.0% | 4.95% | -7.5% |
| Q4 2019 | $31,863,000 | +33.8% | 585,289 | +2.5% | 5.36% | +25.2% |
| Q3 2019 | $23,814,000 | -0.1% | 570,808 | +4.9% | 4.28% | +6.8% |
| Q2 2019 | $23,832,000 | -0.2% | 544,223 | +17.3% | 4.01% | -7.4% |
| Q1 2019 | $23,889,000 | +60.2% | 464,127 | +15.1% | 4.32% | +37.0% |
| Q4 2018 | $14,913,000 | -4.4% | 403,271 | -3.0% | 3.16% | +30.6% |
| Q3 2018 | $15,604,000 | +1.3% | 415,555 | +6.6% | 2.42% | -1.7% |
| Q2 2018 | $15,408,000 | +129.8% | 389,889 | +49.8% | 2.46% | +199.5% |
| Q1 2018 | $6,704,000 | +133.8% | 260,255 | +144.8% | 0.82% | +136.6% |
| Q4 2017 | $2,868,000 | – | 106,312 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |